News
Artificial intelligence is showing promise in improving the detection and management of idiopathic pulmonary fibrosis (IPF), ...
Elicio's mKRAS-targeting cancer vaccine reduced the risk of death by 77% by activating the anti-tumour mechanisms of key ...
8h
Clinical Trials Arena on MSNResponse’s post-GLP-1RA drug reduces weight rebound in Phase II
Response Pharmaceuticals’ drug has helped reduce the amount of weight a patient regains after treatment with glucagon-like ...
DARPA has developed a radio frequency test range to refine to help the US simulate complex RF engagements for modern EW ...
Insmed’s drug Brinsupri (brensocatib) has landed a double regulatory landmark win, becoming both the first marketed ...
PureTech's latest spinoff Celea Therapeutics was created to progress the former's lead respiratory IPF programme, ...
SetPoint Medical has secured $140m in private financing to accelerate the commercialisation of its SetPoint System, a ...
As cyber attacks on major retailers like Pandora continue to hit headlines, experts are urging ecommerce businesses to step ...
Survey suggests power infrastructure is the biggest barrier to investing in battery-electric vehicles (BEVs) in mining.
South Korea is fast becoming a focal point for global biopharmaceutical licensing, with deal values reaching $7.86 billion ...
Novartis' mAb ianalumab helped maintain safe platelet levels for a prolonged period, reducing patient reliance on hospital ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results